Sleep Disorders

What sleep disorders are common in older adults and what are the associated risk factors and correlates?

All in a good night’s sleep? Researchers performed a pharmacovigilance study of second-generation antipsychotics and mood stabilizers as the suspected agent of psychiatric adverse drug reactions (insomnia and suicide/ideation/behavior/death).

Pain can have a substantial impact on sleep quality and quality of life.

New research suggests deliberate control of breathing could help regulate autonomic function in patients who have insomnia.

A hypnotic might be a good option for augmenting depression treatment, but which hypnotic has the best evidence for efficacy?

In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.

In this custom video series, sleep specialists discuss common unmet needs and challenges when treating patients with narcolepsy.

In this custom video series, Haramandeep Singh, MD, and Debra Stultz, MD, discuss the roles and responsibilities of sleep specialists, neurologists, and psychiatrists in the management of narcolepsy.

In this custom video series, experts in sleep medicine discuss patient factors and symptoms they consider when selecting optimal treatment regimens for patients with narcolepsy.

In this custom video series, Debra Stultz, MD, comments on common psychiatric comorbidities seen with narcolepsy and the impact on a patient’s quality of life.

In this custom video series, Haramandeep Singh, MD, and Debra Stultz, MD, discuss a case involving a 23-year-old man with schizoaffective disorder and newly diagnosed narcolepsy.

In this custom video series, Debra Stultz, MD, leads the discussion on the use of pitolisant as initial therapy for a patient newly diagnosed with narcolepsy and cataplexy.

In this custom video series, experts in sleep medicine provide insight on ways cataplexy can present in patients with narcolepsy.

In this custom video series, Haramandeep Singh, MD, and Debra Stultz, MD, discuss a case involving a 20-year-old woman newly diagnosed with narcolepsy and cataplexy, initial impressions, and appropriate provider referral.

This hypersomnia treatment just received an extended approval for cataplexy and excessive daytime sleepiness.

A brain-based perspective could explain how and why psychotherapy leads to enduring change.

In this custom video series, experts in sleep and neuroscience discuss the role of neurologists, psychiatrists, and sleep specialists in the treatment of narcolepsy and comorbid conditions.

In this custom video series, experts discuss the uniqueness of pitolisant as a treatment option within the setting of narcolepsy and the role histamine plays in wakefulness.

In this custom video series, experts discuss the advantages and disadvantages of stimulating agents in the treatment of narcolepsy in addition to other notable pharmacological options.

In this custom video series, Debra Stultz, MD, leads a discussion on behavioral interventions for the treatment of narcolepsy and adaptation of patients in lieu of seeking treatment.

In this custom video series, experts discuss medical and psychiatric illnesses that can be confused with narcolepsy as well as the presence and treatment of psychiatric comorbidities.

In this custom video series, Debra Stultz, MD, and Stephen Stahl, MD, PhD, share insights into diagnosing narcolepsy, including signs to monitor for, testing, and the potential for false negatives.

In this custom video series, experts within the fields of sleep and neuroscience discuss additional symptoms that can occur in patients with narcolepsy and REM cycle abnormalities.

In this custom video series, Debra Stultz, MD, discusses cataplexy, a vague symptom precipitated by strong emotion that can be masked by certain medications.

In this custom video series, experts within the fields of sleep and neuroscience discuss sleep as a vital sign and causes, in addition to narcolepsy, for excessive daytime sleepiness.

In this custom video series, Stephen Stahl, MD, PhD, discusses the underlining cause of narcolepsy and the role of the neurotransmitter orexin (hypocretin) in the stabilization of wakefulness.

Sedation may not always be desirable, but it is difficult to avoid in psychiatry. Some of the most sedating medications are discussed.

Key considerations for healthcare providers seeking to manage their patients’ insomnia.

This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.

The key to better sleep? Stabilizing blood sugar.